Neurite outgrowth inhibitor (Nogo), one of the potential biomarkers for ALS possesses axonal growth inhibitory activity and has a central role in ALS (Fergani et al., 2005). This evidence concerns the gene RTN4 and amyotrophic lateral sclerosis.